Resources / AI-Guided Spatial Profiling of Tertiary Lymphoid Structures in Human Lung Cancer byImaging Mass Cytometry
Phenoplex™
AI-Guided Spatial Profiling of Tertiary Lymphoid Structures in Human Lung Cancer by Imaging Mass Cytometry
Originally presented at SITC 2025
Description

Imaging Mass CytometryTM (IMCTM) technology enables high-dimensional, multiplexed imaging at subcellular resolution without autofluorescence or cyclic imaging. The HyperionTM XTi Imaging System supports three acquisition modes: Preview Mode (PM), Tissue Mode (TM), and Cell Mode (CM). PM provides rapid whole-slide scans for tissue overview within minutes, while TM captures entire tissue sections at 5-μm resolution, mapping over 40 biomarkers to reveal spatial heterogeneity. CM enables high-resolution, single-cell imaging of regions of interest (ROIs) identified in PM. Together with an automated slide loader, these modes support continuous, high-throughput tissue analysis.

Authors and institutions

Katherine Hales1+, Smriti Kala2, David Mason1, James Mansfield2, Regan Baird1, Hiroyuki Suzuki3

  1. Visiopharm A/S, Hørsholm, Denmark
  2. Standard BioTools Canada Inc., Markham, ON, Canada
  3. Fukushima Medical University, Fukushima, Japan
Questions? We’re here to help.
Contact us
Success
Your message has been successfully sent!
Contact us

We are always ready to answer your questions

Helena Nygaard Regev David Mason, Phd.
Headquarters
Agern Allé 24, 2970 Hoersholm, Denmark
Regional legal entities
See our worldwide locations and distributors